OrbusNeich Medical Group Holdings Limited (Stock Code: 6929) has announced that its board of directors will convene on March 12, 2026. The agenda includes reviewing and approving the annual results for the fiscal year ended December 31, 2025, considering a final dividend if applicable, and discussing any other pending matters.
This announcement indicates that the company’s leadership, chaired by Mr. David Chien, will assess the performance of the past financial year, which concluded on December 31, 2025. The directors will also deliberate on the distribution of dividends, subject to final approval. The conclusions from this meeting are expected to be disclosed following the formal board review.